Cardiovascular and Prothrombotic Risk in Patients With Oral Lichen Planus.
NCT ID: NCT07151014
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
55 participants
OBSERVATIONAL
2026-01-31
2027-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cellular and Molecular Biomarkers in Patients With Lichen Planus
NCT06451744
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465
Incidence of Esophageal Lichen Planus in Patients With Known Oral Lichen Planus
NCT02532166
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
NCT00555633
Trichoscopy as a Monitoring Tool for Activity and Remission in Pemphigus Vulgaris: A Clinical Study Supported by Immunological Evaluation.
NCT06863454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
blood sample collection
blood sample collection in old patients in order to study the trombophilic risk
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 18 years
* Patients who agree to sign the informed consent form
Exclusion Criteria
* Patients who do not agree to sign the informed consent form
* Patients without a diagnosis of Oral Lichen Planus
* Patients with previously known cardiac diseases
* History of major cardiovascular events (myocardial infarction, ischemic stroke, TIA)
* Patients with overt heart failure (NYHA class III-IV)
* Cardiomyopathies not related to the studied risk factors (e.g., genetic hypertrophic cardiomyopathy)
* Patients undergoing anticoagulant therapy
* Patients with primary or secondary conditions associated with increased cardiovascular risk
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
7635
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.